Sigurd Lax

ORCID: 0000-0002-3576-601X · 5 papers in corpus
guideline 2023
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1136/ijgc-2023-004429

In 2018, the European Society of Gynecological Oncology (ESGO) jointly with the European Society for Radiotherapy and Oncology (ESTRO) and the European Society of Pathology (ESP) published evidence-based guidelines for the management of pat…

guideline 2023
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023
Virchows Archiv : an international journal of pathology ·doi:10.1007/s00428-023-03552-3

In 2018, the European Society of Gynecological Oncology (ESGO) jointly with the European Society for Radiotherapy and Oncology (ESTRO) and the European Society of Pathology (ESP) published evidence-based guidelines for the management of pat…

review 2013
Targeting signaling pathways in epithelial ovarian cancer
International journal of molecular sciences ·doi:10.3390/ijms14059536

UNLABELLED: Ovarian carcinoma (OC) is the most lethal gynecological malignancy. Response to platinum-based chemotherapy is poor in some patients and, thus, current research is focusing on new therapy options. The various histological types …

2012
Erkrankungen des Endometriums
·doi:10.1007/978-3-642-04564-6_19
2000
The frequency of p53, k‐ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma
·doi:10.1002/(sici)1097-0142(20000215)88:4<814::aid-cncr12>3.3.co;2-l

BACKGROUND The two most common types of uterine endometrial carcinoma, endometrioid (UEC) and serous (USC), differ in their histopathologic appearance and biologic behavior. Recent studies suggest that these differences may be associated wi…